Table of Contents Author Guidelines Submit a Manuscript
Depression Research and Treatment
Volume 2015 (2015), Article ID 835786, 4 pages
http://dx.doi.org/10.1155/2015/835786
Research Article

Memory Impairment following Acute Tricyclic Antidepressants Overdose

1Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3Department of Anesthesiology and Critical Care, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4Department of Clinical Toxicology, Noor and Ali-Asghar (PBUH) University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
5Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Received 26 September 2014; Revised 29 November 2014; Accepted 2 December 2014

Academic Editor: Frans G. Zitman

Copyright © 2015 Nastaran Eizadi-Mood et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. V. Curran, “Tranquillising memories: a review of the effects of benzodiazepines on human memory,” Biological Psychology, vol. 23, no. 2, pp. 179–213, 1986. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Verwey, P. Eling, H. Wientjes, and F. G. Zitman, “Memory impairment in those who attempted suicide by benzodiazepine overdose,” Journal of Clinical Psychiatry, vol. 61, no. 6, pp. 456–459, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Eizadi-Mood, A. M. Sabzghabaee, K. Montazeri et al., “Trend of memory recovery after benzodiazepine overdose,” Iranian Journal of Pharmacology & Therapeutics, vol. 6, no. 1, pp. 11–13, 2007. View at Google Scholar · View at Scopus
  4. S. Grieshaber, A. Jatzko, and G. Adler, “Mnestic impairment under olanzapine overdosage in an elderly patient,” Psychiatrische Praxis, vol. 29, no. 8, pp. 441–444, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. J. Ellenhorn, Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning, Williams and Wilkins, Baltimore, Md, USA, 2nd edition, 1999.
  6. B. Arroll, C. R. Elley, T. Fishman et al., “Antidepressants versus placebo for depression in primary care,” Cochrane Database of Systematic Reviews (Online), vol. 8, no. 3, Article ID CD007954, 2009. View at Google Scholar · View at Scopus
  7. R. D. Gibbons, K. Hur, D. K. Bhaumik, and J. J. Mann, “The relationship between antidepressant medication use and rate of suicide,” Archives of General Psychiatry, vol. 62, no. 2, pp. 165–172, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. S. Dianat, M.-R. Zarei, H. Hassanian-Moghaddam, N. Rashidi-Ranjbar, R. Rahimian, and M. R. Rasouli, “Tricyclic antidepressants intoxication in Tehran, Iran: epidemiology and associated factors,” Human and Experimental Toxicology, vol. 30, no. 4, pp. 283–288, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. Wong, D. M. Taylor, K. Ashby, and J. Robinson, “Changing epidemiology of intentional antidepressant drug overdose in Victoria, Australia,” The Australian and New Zealand Journal of Psychiatry, vol. 44, no. 8, pp. 759–764, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. P. Gerretsen and B. G. Pollock, “Drugs with anticholinergic properties: a current perspective on use and safety,” Expert Opinion on Drug Safety, vol. 10, no. 5, pp. 751–765, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. B. Verwey, J. A. van Waarde, M. A. Bozdag, I. van Rooij, E. de Beurs, and F. G. Zitman, “Reassessment of suicide attempters at home, shortly after discharge from hospital,” Crisis, vol. 31, no. 6, pp. 303–310, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. R. Zarrindast, T. Shamsi, P. Azarmina, P. Rostami, and B. Shafaghi, “GABAergic system and imipramine-induced impairment of memory retention in rats,” European Neuropsychopharmacology, vol. 14, no. 1, pp. 59–64, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Zarrindast Mohammad, M. Ghiasvand, H. Homayoun, P. Rostami, B. Shafaghi, and S. Khavandgar, “Adrenoceptor mechanisms underlying imipramine-induced memory deficits in rats,” Journal of Psychopharmacology, vol. 17, no. 1, pp. 83–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Wechsler, Wechsler Memory Scale—Fourth Edition (WMS-IV UK) Administration and Scoring Manual, The Psychological Corporation, Pearson, San Antonio, Tex, USA, 2009.
  15. D. L. Lamping, B. Spring, and A. J. Gelenberg, “Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study,” Psychopharmacology, vol. 84, no. 2, pp. 254–261, 1984. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Gallassi, R. di Sarro, A. Morreale, and M. Amore, “Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy,” Journal of Affective Disorders, vol. 91, no. 2-3, pp. 243–250, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. S. G. Bryant and C. S. Brown, “Current concepts in clinical therapeutics: major affective disorders, part 2,” Clinical Pharmacy, vol. 5, no. 5, pp. 385–395, 1986. View at Google Scholar · View at Scopus
  18. I. Amado-Boccara, N. Gougoulis, M. F. P. Littre, A. Galinowski, and H. Loo, “Effects of antidepressants on cognitive functions: a review,” Neuroscience & Biobehavioral Reviews, vol. 19, no. 3, pp. 479–493, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. W. J. Ridel and H. M. van Praag, “Avoiding and managing anticholinergic effects of antidepressants,” CNS Drugs, vol. 3, no. 4, pp. 245–259, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Monleón, C. Vinader-Caerols, M. C. Arenas, and A. Parra, “Antidepressant drugs and memory: insights from animal studies,” European Neuropsychopharmacology, vol. 18, no. 4, pp. 235–248, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. J. H. Meador-Woodruff, M. Akil, R. Wisner-Carlson, and L. Grunhaus, “Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels,” Journal of Clinical Psychopharmacology, vol. 8, no. 1, pp. 28–32, 1988. View at Google Scholar · View at Scopus
  22. M. Z. Mintzer and R. R. Griffiths, “Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine,” Experimental and Clinical Psychopharmacology, vol. 13, no. 4, pp. 336–347, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. M. Ghoneim, J. V. Hinrichs, and S. P. Mewaldt, “Dose-response analysis of the behavioral effects of diazepam: I. Learning and memory,” Psychopharmacology, vol. 82, no. 4, pp. 291–295, 1984. View at Publisher · View at Google Scholar · View at Scopus